|Articles|March 1, 2004

Pharmacy Times

  • Volume 0
  • 0

Piperacillin Injection

American Pharmaceutical Partners Inc (Schaumburg, Ill) recently announced FDA approval to launch Piperacillin for Injection USP, the generic equivalent of Wyeth?s Pipracil. Piperacillin is a third-generation antibiotic indicated for the treatment of serious infections caused by designated susceptible microorganisms such as Pseudomonas aeruginosa. This antibiotic is active against a variety of gram-positive and gram-negative aerobic and anaerobic bacteria. These microorganisms are found in a variety of conditions, including intra-abdominal infections, urinary tract infections, gynecologic infections, septicemia, lower respiratory tract infections, skin and skin-structure infections, bone and joint infections, and uncomplicated gonoccocal urethritis. For more information, visit www.appdrugs.com.

Articles in this issue

over 22 years ago

New Technologies Top Survey

over 22 years ago

PDX Software Gets High Marks

over 22 years ago

Seal•ON

over 22 years ago

SaltAire Sinus Relief

over 22 years ago

Zim's Crack Creme Hand Sanitizer

over 22 years ago

CoroWise Plant Sterols

over 22 years ago

Culturelle

Latest CME